by The NFL and NFL Players Association are jointly reviewing the handling of Jalen Hurts’ blood-clot diagnosis. The review is underway, but no findings or conclusions have been announced.
Philadelphia Eagles quarterback Jalen Hurts is expected to miss the remainder of the 2026 season after further medical testing identified deep vein thrombosis and blood clots in both lungs. The NFL and NFLPA confirmed on October 25 that they are working together to review how the case was handled. The immediate priority remains Hurts’ health and recovery, while the review will examine the medical timeline and process.
What the NFL and NFLPA have confirmed
The league and players’ union said they are reviewing the handling of the diagnosis after the NFLPA requested an investigation. The announcement did not include a timetable or findings. That distinction matters: the review is a process to establish the facts, not a public conclusion that a team or medical professional did something wrong.
NFL Commissioner Roger Goodell previously said the league welcomed a review, while the NFL’s chief medical officer defended the work of the Eagles’ medical staff. Those statements represent the league’s position; the joint review has not publicly concluded.
Jalen Hurts: the reported timeline
| Date | What was reported |
|---|---|
| October 4 | Hurts was struck in the calf area during the game against the Los Angeles Rams, according to the Eagles’ account. |
| October 8 | He requested treatment for the calf after practice and informed the medical staff about the earlier contact. |
| October 10 | An ultrasound in London identified a superficial vein thrombosis. Specialists assessed the findings before the October 11 game against Jacksonville. |
| October 15–17 | Follow-up testing indicated movement in the clot. Philadelphia ruled him out, consulted medical experts and later placed him on injured reserve. |
| October 19 | The Eagles and Hurts’ agent disclosed the updated diagnosis of deep vein thrombosis and bilateral pulmonary emboli. |
| October 25 | The NFL and NFLPA announced a joint review of the handling of the case. |
The timeline above summarizes statements from the Eagles and published NFL reporting. Medical decisions can depend on tests, symptoms and specialist evaluations that are not all public, so a complete assessment requires the review—not speculation based on isolated dates.
What the Eagles have said about his recovery
The Eagles and Hurts’ agent said he was clinically stable and that doctors expected a full recovery. The statement said he would not take part in football or other contact activities while being treated with blood thinners. The club also said it expected no long-term effects, while stressing that his health comes first.
The public has not received a final review report, a full account of every medical consultation or a return-to-football date. No date should be assumed until Hurts and his medical team provide an update.
Why the review matters beyond one team
Professional football depends on independent medical judgment, clear communication and careful decisions when an athlete’s health is at stake. A transparent review can help clarify how information moved among the player, team clinicians, specialists and league representatives. The process should be judged by its findings once they are released, rather than by early assumptions.
Philadelphia must also manage the football impact of losing its starting quarterback. That competitive consequence is significant, but it does not change the order of priorities: safe treatment, recovery and a fact-based examination of the timeline.
Follow Sportimatic’s NFL coverage
For current matchups and kickoff information, see the NFL Week 8 schedule and TV guide and the Cowboys–Eagles Week 7 recap.
Sources and further reading
Updated October 28, 2026. This report summarizes published statements and does not offer medical advice or draw conclusions about the ongoing review.
